Phreesia (NYSE:PHR) Raised to “Strong-Buy” at DA Davidson

DA Davidson upgraded shares of Phreesia (NYSE:PHR) to a strong-buy rating in a research note published on Monday,Zacks.com reports.

PHR has been the topic of several other research reports. Needham & Company LLC upped their price target on Phreesia from $29.00 to $35.00 and gave the company a “buy” rating in a research note on Friday. JMP Securities upped their price target on Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a research note on Monday. Truist Financial upped their price target on Phreesia from $35.00 to $36.00 and gave the company a “buy” rating in a research note on Friday. Mizuho assumed coverage on Phreesia in a research note on Wednesday, August 27th. They issued an “outperform” rating and a $36.00 price target on the stock. Finally, KeyCorp upped their price target on Phreesia from $28.00 to $35.00 and gave the company an “overweight” rating in a research note on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating and twelve have issued a Buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $34.08.

Phreesia Stock Performance

NYSE PHR opened at $26.78 on Monday. The stock’s fifty day moving average is $28.31 and its two-hundred day moving average is $26.50. The firm has a market capitalization of $1.59 billion, a P/E ratio of -63.75 and a beta of 0.72. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. Phreesia has a fifty-two week low of $17.07 and a fifty-two week high of $32.76.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.08. The company had revenue of $117.26 million for the quarter, compared to analyst estimates of $116.39 million. Phreesia had a negative return on equity of 9.00% and a negative net margin of 5.35%.The firm’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.03) earnings per share. Phreesia has set its FY 2026 guidance at EPS. On average, research analysts anticipate that Phreesia will post -1.1 earnings per share for the current year.

Insider Activity

In related news, insider Evan Roberts sold 45,147 shares of the stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $32.02, for a total transaction of $1,445,606.94. Following the transaction, the insider owned 727,768 shares of the company’s stock, valued at approximately $23,303,131.36. This represents a 5.84% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Mark Douglas Smith sold 7,000 shares of the stock in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $29.00, for a total value of $203,000.00. Following the transaction, the director directly owned 37,353 shares in the company, valued at approximately $1,083,237. The trade was a 15.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 109,292 shares of company stock worth $3,295,323 in the last quarter. Insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Several hedge funds have recently bought and sold shares of PHR. Northern Trust Corp lifted its stake in Phreesia by 6.6% during the 4th quarter. Northern Trust Corp now owns 571,807 shares of the company’s stock worth $14,387,000 after acquiring an additional 35,392 shares in the last quarter. Ameriprise Financial Inc. acquired a new position in Phreesia during the 4th quarter worth about $269,000. BNP Paribas Financial Markets acquired a new position in Phreesia during the 4th quarter worth about $163,000. Deutsche Bank AG lifted its stake in Phreesia by 95.9% during the 4th quarter. Deutsche Bank AG now owns 57,297 shares of the company’s stock worth $1,442,000 after acquiring an additional 28,047 shares in the last quarter. Finally, Graham Capital Management L.P. lifted its stake in Phreesia by 50.1% during the 4th quarter. Graham Capital Management L.P. now owns 30,026 shares of the company’s stock worth $755,000 after acquiring an additional 10,021 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.